| Identification | Back Directory | [Name]
3(4H)-Quinazolinepropanamide, 6-[5-[[(2-chloro-4-fluorophenyl)sulfonyl]amino]-6-methoxy-3-pyridinyl]-N,α-dimethyl-4-oxo-, (αS)- | [CAS]
2322293-84-3 | [Synonyms]
(S)-PI3Kα-IN-4
3(4H)-Quinazolinepropanamide, 6-[5-[[(2-chloro-4-fluorophenyl)sulfonyl]amino]-6-methoxy-3-pyridinyl]-N,α-dimethyl-4-oxo-, (αS)- | [Molecular Formula]
C25H23ClFN5O5S | [MDL Number]
MFCD33402163 | [MOL File]
2322293-84-3.mol | [Molecular Weight]
560 |
| Hazard Information | Back Directory | [Biological Activity]
(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα, with an IC50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ, PI3Kδ, and PI3Kγ, respectively. (S)-PI3Kα-IN-4 can be used for the research of cancer[1].
(S)-PI3Kα-IN-4 (compound 11) is a quinazolin-4(3H)-one derivative with 2-substituted-N-methylpropanamide substitution[1]. | [References]
[1]. Dong J, et, al. Discovery of 3-Quinazolin-4(3 H)-on-3-yl-2, N-dimethylpropanamides as Orally Active and Selective PI3Kα Inhibitors. ACS Med Chem Lett. 2020 Jun 10;11(7):1463-1469. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|